Dr Andrew E Warner, MD | |
310 15th Ave E, Seattle, WA 98112-5103 | |
(206) 326-3000 | |
Not Available |
Full Name | Dr Andrew E Warner |
---|---|
Gender | Male |
Speciality | Obstetrics/gynecology |
Experience | 15 Years |
Location | 310 15th Ave E, Seattle, Washington |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1518196500 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207V00000X | Obstetrics & Gynecology | ML60394988 (Washington) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Kaiser Foundation Health Plan Of Washington | 9032022579 | 1480 |
News Archive
The Max Planck Florida Institute for Neuroscience, the first and only U.S. extension of the prestigious Max Planck Society, today announced it has received approximately $1,257,500 in grant funding from prestigious national and international organizations to fund research into Parkinson-s, epilepsy and other neurological disorders.
When governments use comprehensive, well-funded tobacco control programs to reduce adult smoking, they also reduce smoking among adolescents. This bonus effect is an important factor to consider as policymakers face pressure to reduce spending on anti-smoking programs.
A variation in the gene FOXO3A has a positive effect on the life expectancy of humans, and is found much more often in people living to 100 and beyond - moreover, this appears to be true worldwide.
Abbott announced today that the U.S. Food and Drug Administration has approved two new strengths for three-month administration of Lupron Depot-PED (leuprolide acetate for depot suspension) for the treatment of children with central precocious puberty (CPP).
› Verified 2 days ago
Entity Name | Kaiser Foundation Health Plan Of Washington |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1396810701 PECOS PAC ID: 9032022579 Enrollment ID: O20031112000454 |
News Archive
The Max Planck Florida Institute for Neuroscience, the first and only U.S. extension of the prestigious Max Planck Society, today announced it has received approximately $1,257,500 in grant funding from prestigious national and international organizations to fund research into Parkinson-s, epilepsy and other neurological disorders.
When governments use comprehensive, well-funded tobacco control programs to reduce adult smoking, they also reduce smoking among adolescents. This bonus effect is an important factor to consider as policymakers face pressure to reduce spending on anti-smoking programs.
A variation in the gene FOXO3A has a positive effect on the life expectancy of humans, and is found much more often in people living to 100 and beyond - moreover, this appears to be true worldwide.
Abbott announced today that the U.S. Food and Drug Administration has approved two new strengths for three-month administration of Lupron Depot-PED (leuprolide acetate for depot suspension) for the treatment of children with central precocious puberty (CPP).
› Verified 2 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Andrew E Warner, MD 310 15th Ave E, Seattle, WA 98112-5103 Ph: (206) 326-3000 | Dr Andrew E Warner, MD 310 15th Ave E, Seattle, WA 98112-5103 Ph: (206) 326-3000 |
News Archive
The Max Planck Florida Institute for Neuroscience, the first and only U.S. extension of the prestigious Max Planck Society, today announced it has received approximately $1,257,500 in grant funding from prestigious national and international organizations to fund research into Parkinson-s, epilepsy and other neurological disorders.
When governments use comprehensive, well-funded tobacco control programs to reduce adult smoking, they also reduce smoking among adolescents. This bonus effect is an important factor to consider as policymakers face pressure to reduce spending on anti-smoking programs.
A variation in the gene FOXO3A has a positive effect on the life expectancy of humans, and is found much more often in people living to 100 and beyond - moreover, this appears to be true worldwide.
Abbott announced today that the U.S. Food and Drug Administration has approved two new strengths for three-month administration of Lupron Depot-PED (leuprolide acetate for depot suspension) for the treatment of children with central precocious puberty (CPP).
› Verified 2 days ago
Dr. Jaime Marie Michaelson, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 310 15th Ave E, Seattle, WA 98112 Phone: 206-326-3000 | |
Alisa Beth Kachikis, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 1959 Ne Pacific St, 3rd Floor Sw 350, Seattle, WA 98195 Phone: 206-598-4070 | |
Karen L. Bohmke, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 1101 Madison St, #1150, Seattle, WA 98104 Phone: 206-386-3400 | |
Lisa S. Callegari, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 1959 Ne Pacific St, Seattle, WA 98195 Phone: 206-520-5000 | |
Anne-marie Elizabeth Amies Oelschlager, Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: Uwmc-roosevelt, 4245 Roosevelt Way Ne, Seattle, WA 98105 Phone: 206-598-5500 | |
Shirley Andrews, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 1560 N 115th St Ste 212, Seattle, WA 98133 Phone: 206-363-2800 Fax: 206-363-2811 | |
Lyndsey Summer Benson, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1959 Ne Pacific St, Box 356460, Seattle, WA 98195 Phone: 610-202-4028 |